Shabbir, A. et al. 2024. Mavacamten’s therapeutic impact: cardiac-specific myosin inhibition in obstructive hypertrophic cardiomyopathy. Global Cardiology. 2, 3 (Nov. 2024). DOI:https://doi.org/10.4081/cardio.2024.48.